Detection Nanoparticle Complexes for Bio-nanoparticle Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting viruses and other bio-nanoparticles (BNPs) often target small sub-units, leading to the detection of fragments rather than complete particles, which can result in false positives and reduced sensitivity and specificity in disease diagnosis and environmental monitoring.
Innovation Solution
The development of detection nanoparticles with an average size of 50 nm or larger, equipped with specific binding agents, that form multi-nanoparticle complexes with BNPs of interest, allowing for size-based detection of complete, functional particles through the formation of larger complexes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current detection methods target small sub-units of BNPs, then detection can be performed, but fragments rather than complete particles are detected leading to false positives
Solution Approach 1:
The detection nanoparticle is segmented into multiple functional components: a core structure (50-200 nm) and surface-bound binding agents that specifically recognize multiple epitopes on the BNP. This segmentation allows the detection system to simultaneously achieve high precision through multiple recognition points while maintaining reliability by requiring complete particle assembly for detection signal generation.
Solution Approach 2:
The detection nanoparticle embeds multiple binding agents on its surface that can simultaneously bind to multiple different epitopes on the same BNP particle. This nested arrangement of binding sites ensures that detection only occurs when the complete BNP structure is present, preventing false positives from fragments while maintaining high detection precision.
2Measurement precision
If detection targets fragments of BNPs, then detection sensitivity increases, but specificity decreases due to detection of degradation remains
Solution Approach 1:
Multiple binding agents targeting different epitopes on the BNP are merged onto a single detection nanoparticle surface. This combining creates a synergistic effect where the detection signal is generated only when all binding agents simultaneously engage their targets on a complete BNP particle, thereby maintaining high sensitivity while achieving high specificity by excluding fragment detection.
Solution Approach 2:
The detection nanoparticle acts as an intermediary structure that mediates between the BNP and the detection signal. Its surface-bound binding agents serve as intermediaries that specifically recognize and bind to multiple epitopes on the complete BNP, ensuring that only intact particles generate detection signals while fragments are excluded, thus resolving the sensitivity-specificity tradeoff.
3Reliability
If size-based detection is used to detect complete BNPs, then specificity increases, but detection complexity increases
Solution Approach 1:
The detection nanoparticle is designed to self-assemble with the BNP through spontaneous binding of its surface-bound binding agents to epitopes on the BNP surface. This self-service mechanism eliminates the need for complex external assembly equipment or multi-step protocols, achieving size-based detection specificity through simple incubation and detection of the formed complexes.
Solution Approach 2:
The detection nanoparticle is designed as a universal platform that can detect various BNP types (viruses, exosomes, bacteria) by simply changing the specific binding agents attached to its surface. This multi-functionality reduces detection method complexity across different applications, as the same core nanoparticle structure can be adapted to detect different targets without requiring entirely new detection systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the sensitivity and specificity of BNP detection by distinguishing between whole particles and fragments, providing rapid and cost-effective results with minimal sample preparation, suitable for disease diagnosis and public health applications.
Implementation Method 1
the detection nanoparticle can bind a plurality of the BNP of interest via the binding agents, the binding forming a multi-nanoparticle complex
Data Source
Figure 1~2
Figure 3
AI summary
The invention relates to a method for detecting a bio-nanoparticle comprising: contacting a test sample comprising a bio-nanoparticle having a size dimension of about 50 nanometers or greater with a detection nanoparticle, the detection nanoparticle having a size dimension of about 50 nanometers or greater, the detection nanoparticle comprising a plurality of binding agents at a surface of the nanoparticle; wherein upon the contact, the detection nanoparticle binds a plurality of the bio-nanoparticle via a specific binding between one of the binding agents and a binding partner of each of the plurality of the bio-nanoparticles, the binding forming a multi-nanoparticle complex that includes multiple bio-nanoparticles and optionally includes multiple detection nanoparticles in a three dimensional complex; and detecting the multi-nanoparticle complex according to a size-detection regime.